Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum
PR Newswire - 2 hrs 17 mins ago
Cancer experts have reported how a Varian Medical Systems (NYSE: VAR) supported project in the area of distributed learning is helping to harness the power of "big data" for the benefit of patients. Speakers at a Varian-hosted symposium at the 3rd ESTRO (European Society for Therapeutic Radiation Oncology) forum in Barcelona detailed the importance of gaining knowledge from each treatment and applying that knowledge to help benefit the next patient.
VAR: 95.50 (-0.64), MDSY: 2.50 (-0.06)
Final Glance: Health Care Equipment companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top health care equipment companies were mixed at the close of trading:
VAR: 95.50 (-0.64), TMO: 130.02 (+0.47)
Midday Glance: Health Care Equipment companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top health care equipment companies are mixed at 1 p.m.:
VAR: 95.50 (-0.64), TMO: 130.02 (+0.47)
Early Glance: Health Care Equipment companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top health care equipment companies are mixed at 10 a.m.:
VAR: 95.50 (-0.64), TMO: 130.02 (+0.47)
USMD Brings World-Class, Patient-Centric Cancer Care to Texarkana, Texas
Business Wire - Thu Apr 23, 8:00AM CDT
USMD Holdings, Inc. (NASDAQ: USMD), a physician-led integrated healthcare system, announced today its wholly owned subsidiary, USMD Cancer Treatment Centers, has opened a new cancer treatment center in Texarkana, Texas. The new Collom & Carney Cancer Treatment Center opens in partnership with Collom & Carney Clinic Association and is located on the campus of Wadley Regional Medical Center.
VAR: 95.50 (-0.64), USMD: 10.39 (+0.02)
Varian Medical Systems Showcases Technology for Planning and Delivering Advanced Radiotherapy and Radiosurgery Treatments at ESTRO 2015 in Barcelona
M2 - Thu Apr 23, 7:21AM CDT
Booths 1700/1800 - Varian Medical Systems (NYSE:VAR), world leader in radiotherapy equipment and software, will demonstrate its full range of radiotherapy planning and delivery systems at the annual ESTRO (European Society for Radiotherapy and Oncology) meeting, taking place in Barcelona from April 24th-28th . The company will also unveil new technology in a special event taking place on Saturday, April 25, at 10:10am in the Varian booth.
VAR: 95.50 (-0.64)
Global Radiotherapy Market Forecast Report, 2020
M2 - Thu Apr 23, 5:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tl88zw/radiotherapy) has announced the addition of the "Radiotherapy Global Market Forecast (2014-2020)" report to their offering. This report analyzes the global markets for Radiotherapy. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance North America (U.S., and Canada), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 5 Radiotherapy Market by Product Type 5.1 Non-Ionizing Radiation 5.2 Ionizing Radiation 5.3 Particle Radiation 5.4 Electron Beams 5.5 Proton Beams 5.6 Neutron Beams 5.7 Carbon Ions 5.8 Alpha and Beta Particles 5.9 Photon Radiations 5.10 Gamma Rays 5.11 X-rays 6 Radiotherapy Market by Technology 6.1 Intensity Modulated Radiation Therapy (IMRT) 6.2 3-D Conformal Radiotherapy (3D CRT) 6.3 Proton Beam Therapy 6.4 Stereotactic Technology 6.5 Tomotherapy 6.6 Adaptive Radiation Therapy 6.7 Systemic Radiation Therapy 7 Radiotherapy Market by Application 7.1 Lung Cancer 7.2 Colorectal Cancer 7.3 Prostate Cancer 7.4 Breast Cancer 7.5 Head & Neck Cancer 7.6 Brain Cancer 7.7 Spine Cancer 7.8 Cervical Cancer 8 Geographical Segmentation 9 Vendor Landscaping 10 Company Profiles - ANSTO - Accuray, Inc. - C. R. Bard, Inc. - Cardinal Health, Inc. - Covidien, Plc - GE Healthcare - IBA Group - Nordion, Inc - Siemens Healthcare - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/tl...diotherapy
VAR: 95.50 (-0.64), CAH: 91.38 (-0.12), ARAY: 9.11 (-0.11)